Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2022-10-07 07:45 am Sale | 13D | GYRE THERAPEUTICS INC. GYRE | SINGER JULIAN D. | 1,082,400 3.440% | -1,165,042 (-51.84%) | View |
| 2022-08-19 4:30 pm Unchanged | 13D | GYRE THERAPEUTICS INC. GYRE | SINGER JULIAN D. | 2,247,442 7.100% | 0 (Unchanged) | View |
| 2022-08-03 4:17 pm Unchanged | 13D | GYRE THERAPEUTICS INC. GYRE | SINGER JULIAN D. | 2,247,442 7.100% | 0 (Unchanged) | View |
| 2022-07-22 2:21 pm Purchase | 13D | GYRE THERAPEUTICS INC. GYRE | SINGER JULIAN D. | 2,247,442 7.100% | 232,610 (+11.54%) | View |
| 2022-06-17 4:30 pm Unchanged | 13D | GYRE THERAPEUTICS INC. GYRE | SINGER JULIAN D. | 2,014,832 6.400% | 0 (Unchanged) | View |
| 2022-05-25 5:01 pm Purchase | 13D | GYRE THERAPEUTICS INC. GYRE | SINGER JULIAN D. | 2,014,832 6.400% | 702,300 (+53.51%) | View |
| 2022-05-10 4:58 pm Unchanged | 13D | GYRE THERAPEUTICS INC. GYRE | SINGER JULIAN D. | 1,312,532 4.170% | 0 (Unchanged) | View |
| 2022-05-02 5:27 pm Unchanged | 13D | GYRE THERAPEUTICS INC. GYRE | SINGER JULIAN D. | 1,312,532 4.170% | 0 (Unchanged) | View |
| 2022-04-21 1:09 pm Unchanged | 13D | GYRE THERAPEUTICS INC. GYRE | SINGER JULIAN D. | 1,312,532 4.170% | 0 (Unchanged) | View |
| 2022-03-16 08:00 am Unchanged | 13D | GYRE THERAPEUTICS INC. GYRE | SINGER JULIAN D. | 1,312,532 4.180% | 0 (Unchanged) | View |
| 2022-03-07 3:53 pm Unchanged | 13D | GYRE THERAPEUTICS INC. GYRE | SINGER JULIAN D. | 1,312,532 4.180% | 0 (Unchanged) | View |
| 2022-02-28 1:16 pm Purchase | 13D | GYRE THERAPEUTICS INC. GYRE | SINGER JULIAN D. | 1,312,532 4.180% | 71,700 (+5.78%) | View |
| 2022-02-22 7:04 pm Purchase | 13D | GYRE THERAPEUTICS INC. GYRE | SINGER JULIAN D. | 1,240,832 3.950% | 460,400 (+58.99%) | View |
| 2022-01-27 11:56 am Unchanged | 13D | GYRE THERAPEUTICS INC. GYRE | SINGER JULIAN D. | 780,432 2.480% | 0 (Unchanged) | View |
| 2022-01-05 5:29 pm Purchase | 13D | GYRE THERAPEUTICS INC. GYRE | SINGER JULIAN D. | 780,432 2.480% | 120,000 (+18.17%) | View |
| 2021-10-25 9:08 pm Purchase | 13D | GYRE THERAPEUTICS INC. GYRE | SINGER JULIAN D. | 660,432 2.110% | 261,594 (+65.59%) | View |
| 2021-03-19 6:51 pm Sale | 13G | INNOVATE Corp. VATE | SINGER JULIAN D. | 0 0.000% | -3,262,514 (Position Closed) | View |
| 2020-08-03 07:33 am Sale | 13G | INNOVATE Corp. VATE | SINGER JULIAN D. | 3,262,514 6.800% | -115,583 (-3.42%) | View |
| 2020-05-18 9:02 pm Purchase | 13D | INNOVATE Corp. VATE | SINGER JULIAN D. | 3,378,097 7.260% | 303,245 (+9.86%) | View |
| 2020-04-22 06:11 am Purchase | 13D | INNOVATE Corp. VATE | SINGER JULIAN D. | 3,074,852 6.660% | 105,931 (+3.57%) | View |